CELEBREX
Drug timelines are a Plus or Pro feature.
76 regulatory and trial events tracked for CELEBREX, covering 2006-12-05 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population [Phase 2]